Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James O. Armitage files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gary W. Pace - $1.04M in CRDF purchases and sales in the last 12 months
- Mani Mohindru - $80K in CRDF purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James O. Armitage?
James O. Armitage is a corporate insider of Cardiff Oncology, Inc. (CRDF). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did James O. Armitage last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 2 filings going back to 2025.